Cargando…

Brincidofovir Use after Foscarnet Crystal Nephropathy in a Kidney Transplant Recipient with Multiresistant Cytomegalovirus Infection

Background. Cytomegalovirus (CMV) antiviral drug resistance constitutes an increasing challenge in transplantation. Foscarnet is usually proposed when resistance for ganciclovir is suspected, but its use is limited by its nephrotoxicity. Case Presentation. We report a case of multiresistant CMV dise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vial, Romain, Zandotti, Christine, Alain, Sophie, Decourt, Alexandre, Jourde-Chiche, Noémie, Purgus, Raj, Bornet, Charleric, Daniel, Laurent, Moal, Valérie, Legris, Tristan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350387/ https://www.ncbi.nlm.nih.gov/pubmed/28348914 http://dx.doi.org/10.1155/2017/3624146

Ejemplares similares

New treatment options for lupus – a focus on belimumab
por: Chiche, Laurent, et al.
Publicado: (2012)

Foscarnet-Resistant Cytomegalovirus Esophagitis with Stricturing
por: Gaduputi, Vinaya, et al.
Publicado: (2013)

Ganciclovir-Resistant Cytomegalovirus Infection in a Kidney Transplant Recipient Successfully Treated with Foscarnet and Everolimus
por: Menghi, Viola, et al.
Publicado: (2016)

Foscarnet treatment of cytomegalovirus infection in haploidentical or unrelated donor transplants
por: Metafuni, Elisabetta, et al.
Publicado: (2018)

Brincidofovir (CMX001) for the Treatment of Severe Adenoviral Pneumonia in Kidney Transplant Recipient
por: Sudhindra, Praveen, et al.
Publicado: (2019)

Analysis of Mutations in the Gene Encoding Cytomegalovirus DNA Polymerase in a Phase 2 Clinical Trial of Brincidofovir Prophylaxis
por: Lanier, E. Randall, et al.
Publicado: (2016)

Experimental Treatment of Ebola Virus Disease with Brincidofovir
por: Dunning, Jake, et al.
Publicado: (2016)

Endothelial Toxicity of High Glucose and its by-Products in Diabetic Kidney Disease
por: Dou, Laetitia, et al.
Publicado: (2019)

Reply to ‘Kidney involvement in hereditary transthyretin amyloidosis: is there a role for cystatin C?’
por: Solignac, Justine, et al.
Publicado: (2022)

The Role of Brincidofovir in Preparation for a Potential Smallpox Outbreak
por: Foster, Scott A., et al.
Publicado: (2017)

Parvovirus B19 infection and kidney injury: report of 4 cases and analysis of immunization and viremia in an adult cohort of 100 patients undergoing a kidney biopsy
por: Kauffmann, Maëlis, et al.
Publicado: (2020)

Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infection
por: Faure, Emmanuel, et al.
Publicado: (2016)

The Successful Treatment of a Cord Blood Transplant Recipient with Varicella Zoster Virus Meningitis, Radiculitis and Myelitis with Foscarnet
por: Shimizu, Ryo, et al.
Publicado: (2017)

CMV retinitis in a stem cell transplant recipient treated with foscarnet intravitreal injection and CMV specific immunoglobulins
por: Vassallo, Francesco, et al.
Publicado: (2020)

Moving Past Ganciclovir and Foscarnet: Advances in CMV Therapy
por: Hakki, Morgan
Publicado: (2020)

Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infection: Erratum
Publicado: (2017)

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
por: Marty, Francisco M., et al.
Publicado: (2018)

Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection
por: Chan, Shuk Ying, et al.
Publicado: (2021)

Use of Foscarnet Therapy for EBV Infection following Control of PTLD with Enhancement of Cellular Immunity in a Lung-Transplant Recipient
por: Afshar, Kamyar, et al.
Publicado: (2011)

Foscarnet-induced genital lesions: An overview with a case report
por: Adalsteinsson, Jonas A., et al.
Publicado: (2018)

Weaning Maintenance Therapy in Lupus Nephritis: For Whom, When, and How?
por: Jourde-Chiche, Noémie, et al.
Publicado: (2023)

The Place of Immunotherapy in the Management of HCV-Induced Vasculitis: An Update
por: Chiche, Laurent, et al.
Publicado: (2012)

Phosphonoformate Crystalluria, A Warning Signal of Foscarnet-Induced Kidney Injury
por: Deffert, Christine, et al.
Publicado: (2020)

Foscarnet-Type Inorganic-Organic Hybrid Nanoparticles for Effective Antiviral Therapy
por: Khorenko, Mikhail, et al.
Publicado: (2022)

Use of letermovir‐valganciclovir combination as a step‐down treatment after foscarnet for ganciclovir‐resistant CMV infection in kidney transplant recipients
por: Rho, Elena, et al.
Publicado: (2021)

Original Approach for Automated Quantification of Antinuclear Autoantibodies by Indirect Immunofluorescence
por: Bertin, Daniel, et al.
Publicado: (2013)

Pharmacokinetics (PK) and Safety of Intravenous (IV) Brincidofovir (BCV) in Healthy Adult Subjects
por: Wire, Mary Beth, et al.
Publicado: (2017)

Risk factors for severity of COVID-19 in chronic dialysis patients from a multicentre French cohort
por: Lano, Guillaume, et al.
Publicado: (2020)

Foscarnet Therapy for Pure Red Cell Aplasia Related to Human Parvovirus B19 Infection in Kidney Transplant Recipients: A Preliminary Exploration
por: Yu, Yedong, et al.
Publicado: (2021)

Serum GlycA Level Is Elevated in Active Systemic Lupus Erythematosus and Correlates to Disease Activity and Lupus Nephritis Severity
por: Dierckx, Tim, et al.
Publicado: (2020)

Intravenous Foscarnet With Topical Cidofovir for Chronic Refractory Genital Herpes in a Patient With AIDS
por: Usoro, Agnes, et al.
Publicado: (2015)

A case of Epstein-Barr virus acute retinal necrosis successfully treated with foscarnet
por: Suzuki, Kayo, et al.
Publicado: (2022)

In vitro and in vivo evaluation of benzathine foscarnet microcrystals as a potential intravitreal drug depot
por: Wang, Jiaxing, et al.
Publicado: (2019)

Acute retinal necrosis: time to consider double dose of Foscarnet in the first 72 hours
por: Hermoso-Fernández, Francisco Manuel, et al.
Publicado: (2021)

Successful Treatment of Adenovirus Infection with Brincidofovir in an Immunocompromised Patient after Hematological Stem Cell Transplantation
por: Van Genechten, T., et al.
Publicado: (2020)

Brincidofovir is a robust replication inhibitor against African swine fever virus in vivo and in vitro
por: Guo, Shibang, et al.
Publicado: (2023)

Presence of specific SARS-COV2 antibodies in hemodialysis patients and their caregivers after the first wave of COVID-19
por: Robert, Thomas, et al.
Publicado: (2022)

Sequential development of ANCA‐associated vasculitis and anti‐GBM disease: A report of two cases
por: Le Moine, Camille, et al.
Publicado: (2021)

Dihydropyrimidinones Against Multiresistant Bacteria
por: Castro Jara, Marisa, et al.
Publicado: (2022)

Successful Treatment of Epstein-Barr Virus-Induced Necrotizing Retinitis with Intravitreous Ganciclovir, Foscarnet, and Methotrexate
por: Cho, Junsang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_89snj8i84em5n0ddsehkbp5ap9